Q2 2025 13F Holders as of 30 Jun 2025
-
Type / Class
-
Equity / COM
-
Number of holders
-
46
-
Total 13F shares, excl. options
-
3.24M
-
Shares change
-
+1.18M
-
Total reported value, excl. options
-
$24.2M
-
Value change
-
+$8.41M
-
Put/Call ratio
-
1.13
-
Number of buys
-
34
-
Number of sells
-
-14
-
Price
-
$7.47
Significant Holders of Nuvectis Pharma, Inc. - COM (NVCT) as of Q2 2025
58 filings reported holding NVCT - Nuvectis Pharma, Inc. - COM as of Q2 2025.
Nuvectis Pharma, Inc. - COM (NVCT) has 46 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 3.24M shares
.
Largest 10 shareholders include VANGUARD GROUP INC (667K shares), BlackRock, Inc. (643K shares), IRIDIAN ASSET MANAGEMENT LLC/CT (373K shares), BALDWIN WEALTH PARTNERS LLC/MA (350K shares), GEODE CAPITAL MANAGEMENT, LLC (285K shares), STATE STREET CORP (114K shares), NORTHERN TRUST CORP (110K shares), OPPENHEIMER & CO INC (69.1K shares), MARSHALL WACE, LLP (63.6K shares), and FORBES J M & CO LLP (59K shares).
This table shows the top 46 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.